Pulse Biosciences Inc (DE) (PLSE) Key Ratios

$53.24

up-down-arrow $-1.47 (-2.69%)

As on 04-Sep-2026 16:00EDT

Market cap

info icon

$3,797 Mln

Revenue (TTM)

info icon

$1 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

39.2

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 8.23 -- -52.52 411.30 59.72
EBIT -- -- 17.73 -8.15 1.31
Net Profit -32.70 -28.64 -17.68 -33.45 -7.45
EPS -29.99 -25.06 -9.50 1.10 8.43
Book Value -- -- -39.15 -- 5.80
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-25Dec-24
EBIT-Margin info 217,991.60105,811.37-4,723.04-20,794.57--
Net Margin info -----6,755.78----
Return on equity info -114.07-182.08-88.87-74.45-67.31
Return on Capital info -65.17-89.76---68.68-60.46
Return on Assets info -60.41-80.53-62.60-63.68-55.93
Debt to Equity (x) info ----0.000.090.08
ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Pulse Biosciences Inc (DE) (PLSE)
--
-68.68
-60.46
-66.36
-97.73
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

-88.87

Lower than Peers by 93.85

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Pulse Biosciences Inc (DE) (PLSE)
-88.87
-74.45
-67.31
-200.47
-352.57
Peer Median
4.98
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-62.60

Lower than Peers by 65.06

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Pulse Biosciences Inc (DE) (PLSE)
-62.60
-63.68
-55.93
-61.61
-89.24
Peer Median
2.46
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-4,723.04

Lower than Peers by 4,731.56

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Pulse Biosciences Inc (DE) (PLSE)
-4,723.04
-20,794.57
--
456,777.78
-8,293.86
Peer Median
8.53
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-6,755.78

Lower than Peers by 6,760.53

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Pulse Biosciences Inc (DE) (PLSE)
-6,755.78
-20,794.57
--
469,000.00
-8,421.86
Peer Median
4.75
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

-0.01

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Pulse Biosciences Inc (DE) (PLSE)
-0.01
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Revenue Growth

-52.52

Lower than Peers by 61.30

Year on year growth in net sales

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Pulse Biosciences Inc (DE) (PLSE)
-52.52
--
1.00
-1.01
-0.51
Peer Median
8.78
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

17.73

Higher than Peers by 6.70

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Pulse Biosciences Inc (DE) (PLSE)
17.73
-35.82
-30.35
29.19
7.87
Peer Median
11.03
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-17.68

Lower than Peers by 31.43

Year on year growth in profit after tax

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Pulse Biosciences Inc (DE) (PLSE)
-17.68
-35.82
-26.95
28.40
6.66
Peer Median
13.75
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-9.50

Lower than Peers by 30.93

Year on year growth in earnings per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Pulse Biosciences Inc (DE) (PLSE)
-9.50
-0.18
-0.20
0.52
0.26
Peer Median
21.44
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

-7.42

Lower than Peers by 14.24

Year on year growth in book value per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Pulse Biosciences Inc (DE) (PLSE)
-7.42
--
--
--
--
Peer Median
6.82
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Pulse Biosciences Inc (DE) (PLSE)
--
0.09
0.08
0.21
-33.79
Peer Median
0.40
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

0.02

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Pulse Biosciences Inc (DE) (PLSE)
0.02
0.02
0.01
0.02
-0.81
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

9.63

Higher than Peers by 6.93

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Pulse Biosciences Inc (DE) (PLSE)
9.63
10.53
11.88
6.76
10.39
Peer Median
2.70
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

9.61

Higher than Peers by 7.58

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Pulse Biosciences Inc (DE) (PLSE)
9.61
10.51
11.88
--
10.39
Peer Median
2.03
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Pulse Biosciences Inc (DE) (PLSE)
--
--
--
-37.37
-129.59
Peer Median
5.02
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

10.30

Lower than Peers by 6.10

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Pulse Biosciences Inc (DE) (PLSE)
10.30
78.29
--
--
--
Peer Median
16.39
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.01

Lower than Peers by 0.49

Sales / Average Total Assets

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Pulse Biosciences Inc (DE) (PLSE)
0.01
0.00
--
0.00
0.01
Peer Median
0.50
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Pulse Biosciences Inc (DE) (PLSE)
--
142.97
--
--
15.91
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Pulse Biosciences Inc (DE) (PLSE)
--
15.43
--
--
89.05
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Pulse Biosciences Inc (DE) (PLSE)
--
504.77
544.00
515.80
68.45
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Pulse Biosciences Inc (DE) (PLSE)
--
-346.37
--
-515.80
36.51
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Pulse Biosciences Inc (DE) (PLSE)
--
-12.71
-18.97
-15.97
-1.75
Peer Median
46.09
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

39.18

Higher than Peers by 35.40

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Pulse Biosciences Inc (DE) (PLSE)
39.18
11.47
8.85
15.19
-45.87
Peer Median
3.78
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Pulse Biosciences Inc (DE) (PLSE)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

-1.81

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Pulse Biosciences Inc (DE) (PLSE)
-1.81
-11.88
-17.32
-16.01
-2.08
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

3,797

Higher than Peers by 3,262

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Pulse Biosciences Inc (DE) (PLSE)
3,797
--
--
--
--
Peer Median
535
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...